Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasis

Abstract Chronic kidney disease (CKD) stands as a formidable global health challenge, often advancing to end-stage renal disease (ESRD) with devastating morbidity and mortality. At the central of this progression lies podocyte injury, a critical determinant of glomerular dysfunction. Compound K (CK)...

Full description

Saved in:
Bibliographic Details
Main Authors: Fugang Huang, Shuo Huang, Ke Sun, Yanhao Chen, Guanqun Xie, Jie Bao, Yongsheng Fan
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-84704-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559627284611072
author Fugang Huang
Shuo Huang
Ke Sun
Yanhao Chen
Guanqun Xie
Jie Bao
Yongsheng Fan
author_facet Fugang Huang
Shuo Huang
Ke Sun
Yanhao Chen
Guanqun Xie
Jie Bao
Yongsheng Fan
author_sort Fugang Huang
collection DOAJ
description Abstract Chronic kidney disease (CKD) stands as a formidable global health challenge, often advancing to end-stage renal disease (ESRD) with devastating morbidity and mortality. At the central of this progression lies podocyte injury, a critical determinant of glomerular dysfunction. Compound K (CK), a bioactive metabolite derived from ginsenoside, has emerged as a compelling candidate for nephroprotective therapy. Here, we unveil the profound therapeutic potential of CK in a folic acid (FA)-induced CKD mouse model, demonstrating its ability to restore renal function and mitigate podocyte injury. CK exerted its nephroprotective effects by reinforcing inter-podocyte junctions, suppressing aberrant podocyte motility, and preventing podocyte detachment and apoptosis, thereby safeguarding the glomerular filtration barrier. Mechanistically, we identified mitochondrial dysregulation as a key driver of excessive oxidative stress, which is commonly associated with podocyte damage. CK remarkably restored mitochondrial homeostasis by attenuating pathological mitochondrial fission and enhancing mitophagy, thereby rebalancing the delicate mitochondrial network. Intriguingly, CK may disrupt the formation of the Drp1-Bax dimer, a crucial mediator of mitochondrial apoptosis, further averting podocyte loss. Collectively, our findings highlight CK as a potent nephroprotective agent, offering a novel therapeutic avenue for CKD management and redefining possibilities in the battle against progressive renal disease.
format Article
id doaj-art-e04c3003d18149d2b76dc0e372aec5ab
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e04c3003d18149d2b76dc0e372aec5ab2025-01-05T12:20:14ZengNature PortfolioScientific Reports2045-23222025-01-0115111810.1038/s41598-024-84704-6Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasisFugang Huang0Shuo Huang1Ke Sun2Yanhao Chen3Guanqun Xie4Jie Bao5Yongsheng Fan6The First School of Clinical Medicine, Zhejiang Chinese Medical UniversitySchool of Basic Medical Sciences, Zhejiang Chinese Medical UniversityThe Third School of Clinical Medicine, Zhejiang Chinese Medical UniversityThe First School of Clinical Medicine, Zhejiang Chinese Medical UniversitySchool of Basic Medical Sciences, Zhejiang Chinese Medical UniversitySchool of Basic Medical Sciences, Zhejiang Chinese Medical UniversityThe Second Affiliated Hospital of Zhejiang Chinese Medical UniversityAbstract Chronic kidney disease (CKD) stands as a formidable global health challenge, often advancing to end-stage renal disease (ESRD) with devastating morbidity and mortality. At the central of this progression lies podocyte injury, a critical determinant of glomerular dysfunction. Compound K (CK), a bioactive metabolite derived from ginsenoside, has emerged as a compelling candidate for nephroprotective therapy. Here, we unveil the profound therapeutic potential of CK in a folic acid (FA)-induced CKD mouse model, demonstrating its ability to restore renal function and mitigate podocyte injury. CK exerted its nephroprotective effects by reinforcing inter-podocyte junctions, suppressing aberrant podocyte motility, and preventing podocyte detachment and apoptosis, thereby safeguarding the glomerular filtration barrier. Mechanistically, we identified mitochondrial dysregulation as a key driver of excessive oxidative stress, which is commonly associated with podocyte damage. CK remarkably restored mitochondrial homeostasis by attenuating pathological mitochondrial fission and enhancing mitophagy, thereby rebalancing the delicate mitochondrial network. Intriguingly, CK may disrupt the formation of the Drp1-Bax dimer, a crucial mediator of mitochondrial apoptosis, further averting podocyte loss. Collectively, our findings highlight CK as a potent nephroprotective agent, offering a novel therapeutic avenue for CKD management and redefining possibilities in the battle against progressive renal disease.https://doi.org/10.1038/s41598-024-84704-6Chronic kidney diseaseCompound KPodocyte InjuryApoptosisMitochondrial homeostasis
spellingShingle Fugang Huang
Shuo Huang
Ke Sun
Yanhao Chen
Guanqun Xie
Jie Bao
Yongsheng Fan
Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasis
Scientific Reports
Chronic kidney disease
Compound K
Podocyte Injury
Apoptosis
Mitochondrial homeostasis
title Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasis
title_full Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasis
title_fullStr Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasis
title_full_unstemmed Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasis
title_short Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasis
title_sort protective effect of compound k against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasis
topic Chronic kidney disease
Compound K
Podocyte Injury
Apoptosis
Mitochondrial homeostasis
url https://doi.org/10.1038/s41598-024-84704-6
work_keys_str_mv AT fuganghuang protectiveeffectofcompoundkagainstpodocyteinjuryinchronickidneydiseasebymaintainingmitochondrialhomeostasis
AT shuohuang protectiveeffectofcompoundkagainstpodocyteinjuryinchronickidneydiseasebymaintainingmitochondrialhomeostasis
AT kesun protectiveeffectofcompoundkagainstpodocyteinjuryinchronickidneydiseasebymaintainingmitochondrialhomeostasis
AT yanhaochen protectiveeffectofcompoundkagainstpodocyteinjuryinchronickidneydiseasebymaintainingmitochondrialhomeostasis
AT guanqunxie protectiveeffectofcompoundkagainstpodocyteinjuryinchronickidneydiseasebymaintainingmitochondrialhomeostasis
AT jiebao protectiveeffectofcompoundkagainstpodocyteinjuryinchronickidneydiseasebymaintainingmitochondrialhomeostasis
AT yongshengfan protectiveeffectofcompoundkagainstpodocyteinjuryinchronickidneydiseasebymaintainingmitochondrialhomeostasis